| Challenges in fecal donor selection and screening for fecal microbiota transplantation: a review MH Woodworth, C Carpentieri, KL Sitchenko, CS Kraft Gut microbes 8 (3), 225-237, 2017 | 103 | 2017 |
| Laboratory testing of donors and stool samples for fecal microbiota transplantation for recurrent Clostridium difficile infection MH Woodworth, EM Neish, NS Miller, T Dhere, EM Burd, C Carpentieri, ... Journal of clinical microbiology 55 (4), 1002-1010, 2017 | 70 | 2017 |
| Stress-induced increases in depression-like and cocaine place-conditioned behaviors are reversed by disruption of memories during reconsolidation KA Hymel, SO Eans, KL Sitchenko, SM Gomes, AL Lukowsky, JM Medina, ... Behavioural pharmacology 25 (5 and 6), 599-608, 2014 | 20 | 2014 |
| Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement MH Woodworth, RE Conrad, M Haldopoulos, SM Pouch, A Babiker, ... Science Translational Medicine 15 (720), eabo2750, 2023 | 10 | 2023 |
| Ethical considerations in microbial therapeutic clinical trials MH Woodworth, KL Sitchenko, C Carpentieri, RJ Friedman-Moraco, ... The New Bioethics 23 (3), 210-218, 2017 | 7 | 2017 |
| Decreasing early deaths in acute promyelocytic leukemia (APL) by using a simplified treatment algorithm and establishing a network with academic and community centers in USA A Jillella, M Arellano, A Bashey, SI Vidito, RK Stuart, C Leung, ... Blood 126 (23), 3779, 2015 | 4 | 2015 |
| Tacrolimus concentration to dose ratio in solid organ transplant patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection MH Woodworth, CS Kraft, EJ Meredith, AK Mehta, T Wang, YT Mamo, ... Transplant Infectious Disease 20 (2), e12857, 2018 | 3 | 2018 |
| Durability and long-term clinical outcomes of fecal microbiota transplant (FMT) treatment in patients with recurrent C. difficile infection Y Mamo, M Woodworth, K Sitchenko, T Dhere, C Kraft Open Forum Infect Dis 4 (Suppl 1), S384-S385, 2017 | 3 | 2017 |
| A prospective multi-center trial shows reduction of early deaths (ED) and improved survival in elderly acute promyelocytic leukemia (APL) patients (> 60 years). Results of … V Kota, P Karkhanis, R Sharma, S Bolds, K Sitchenko, A Shrestha, ... Blood 128 (22), 1622, 2016 | 3 | 2016 |
| A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute … A Jillella, P Karkhanis, R Sharma, S Bolds, A Shrestha, K Sitchenko, ... Blood 128 (22), 2793, 2016 | 1 | 2016 |
| DECREASING EARLY DEATHS IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN AN ACADEMIC CENTER IN THE US BY USING A SIMPLIFIED TREATMENT ALGORITHM AND DEDICATED APL EXPERTS A Jillella, M Mody, G Harpaul, M Arellano, H Khoury, Z Al-Kadhimi, ... HAEMATOLOGICA 101, 675-676, 2016 | | 2016 |
